AMR - One Health Consortium, University of Calgary, Calgary, AB, Canada.
Department of Production Animal Health, Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada.
BMC Vet Res. 2022 Jun 10;18(1):220. doi: 10.1186/s12917-022-03305-5.
Antimicrobial resistance is a complex One Health issue that exists in both human and veterinary medicine. To mitigate this ever-growing problem, efforts have been made to develop guidelines for appropriate antimicrobial use (AMU) across sectors. In veterinary medicine, there are notable literature gaps for proper AMU in minor species. We conducted a structured narrative review covering the years of July 2006 - July 2021 to find antimicrobial treatments for common bacterial infections in exotic (birds, rodents, reptiles, and others), small flock (chickens, turkeys, and other fowl), and backyard small ruminant (sheep and goats) species. We retrieved a total of 4728 articles, of which 21 articles met the criteria for our review. Studies were grouped according to species, syndrome, and body system affected. Other data extracted included the bacterial pathogen(s), treatment (active ingredient), and geographical origin. Body systems reported included: intra-oral (n = 4), gastrointestinal (n = 1), respiratory (n = 2), reproductive (n = 1), skin (n = 3), aural (n = 1), ocular (n = 4), and other/multisystem (n = 5). By species, our search resulted in: rabbit (n = 5), rat (n = 2), guinea pig (n = 1), chinchilla (n = 1), guinea pig and chinchilla (n = 1), avian species (n = 1), psittacine birds (n = 2), loris and lorikeets (n = 1), turtles (n = 2), lizards (n = 1), goats (n = 2) and sheep (n = 2). The results of our findings identified a distinct gap in consistent antimicrobial treatment information for commonly encountered bacterial conditions within these species. There is a persisting need for clinical trials that focus on antibacterial treatment to strengthen the evidence base for AMU within exotic, small flock, and backyard small ruminant species.
抗微生物药物耐药性是一个复杂的“同一健康”问题,存在于人类和兽医医学中。为了减轻这一日益严重的问题,已经做出努力来制定跨部门合理使用抗微生物药物的指南。在兽医医学中,对于小型物种的合理使用抗微生物药物,存在显著的文献空白。我们进行了一项结构叙述性综述,涵盖了 2006 年 7 月至 2021 年 7 月的年份,以寻找针对外来(鸟类、啮齿动物、爬行动物和其他动物)、小型禽类(鸡、火鸡和其他家禽)和后院小型反刍动物(绵羊和山羊)物种常见细菌感染的抗菌治疗方法。我们共检索到 4728 篇文章,其中 21 篇符合我们的综述标准。研究根据物种、综合征和受影响的身体系统进行分组。提取的其他数据包括细菌病原体、治疗方法(活性成分)和地理来源。报告的身体系统包括:口腔内(n=4)、胃肠道(n=1)、呼吸道(n=2)、生殖(n=1)、皮肤(n=3)、耳部(n=1)、眼部(n=4)和其他/多系统(n=5)。按物种分类,我们的搜索结果包括:兔(n=5)、大鼠(n=2)、豚鼠(n=1)、龙猫(n=1)、龙猫和豚鼠(n=1)、禽类(n=1)、凤头鹦鹉(n=2)、懒猴和吸蜜鹦鹉(n=1)、海龟(n=2)、蜥蜴(n=1)、山羊(n=2)和绵羊(n=2)。我们研究结果表明,这些物种中常见细菌病的一致抗菌治疗信息存在明显差距。需要进行临床试验来集中研究抗菌治疗方法,以加强外来、小型禽类和后院小型反刍动物物种中合理使用抗微生物药物的证据基础。